The approval of perpetual futures contracts in the US may expose traders to unforeseen tax and regulatory challenges if these products are ultimately deemed to be swaps rather than futures, a concern voiced by CME Group Chairman and CEO Terry Duffy. In an interview, Duffy emphasized the ambiguity surrounding the tax implications for US participants, citing the legal distinction between swaps and futures.
The comments come amidst an ongoing legal dispute between CME and the Commodity Futures Trading Commission (CFTC) regarding the regulator's approval of perpetual futures contracts. The core issue revolves around whether perpetual futures should be legally categorized as swaps or futures, with Duffy arguing that they should be considered swaps due to the periodic funding payments exchanged between long and short positions. This designation could have significant tax implications, as gains and losses from futures are typically treated as 60% long-term and 40% short-term capital gains under Section 1256 of the US tax code, whereas swaps are taxed under 'ordinary' taxation.
However, the IRS has not provided guidance on the tax treatment of perpetual futures, leaving market participants uncertain about how to report these positions. Legal experts note that the issue is complex, with the statutory definition of swaps being broad and the economic function of perpetual futures resembling that of traditional futures.
The outcome of the court case and potential IRS guidance will be crucial in determining the tax implications for traders involved in perpetual futures, with Duffy warning that institutions could face uncertainty and potential tax liabilities if the classification of these contracts changes.